(task) New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy

Begin forwarded message:

From: Kathy Gilbeaux <redacted>

Subject: New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy

Date: January 20, 2021 at 5:17:40 PM EST

To: "michael.d.mcdonald@mac.com" <michael.d.mcdonald@mac.com>, "mbkraft@erols.com" <mbkraft@erols.com>, "gavinms@gmail.com" <gavinms@gmail.com>, "ssm20@cumc.columbia.edu" <ssm20@cumc.columbia.edu>

Reply-To: Kathy Gilbeaux <redacted>

Mike / Mike K. / Gavin / Steve

 

FYI . . . South African 501Y.V2 variant . . . 

 

New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy

https://www.reuters.com/article/health-coronavirus-safrica-variant-int/new-covid-19-variant-defeats-plasma-treatment-may-reduce-vaccine-efficacy-idUSKBN29P2H9

 

RESEARCH - SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

https://doi.org/10.1101/2021.01.18.427166

 

Kathy